Aeglea raises $50M in IPO after slashing share price

John Carroll

Austin, TC-based BioTherapeutics raised $ 50 million in its IPO pricing 5 million shares at $ 10 each, far below the range that it had set out for itself.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS